About this trial
The goal of this observational study is to learn about the long-term prognostic of coronary microvascular dysfuction in Patients with Dilated Cardiomyopathy.
The main question it aims to answer is: Does the coronary microvascular dysfunction impact the outcomes in Patients with Dilated Cardiomyopathy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Dilated cardiomyopathy comfirmed by echocardiography: LVDd > 55 mm in men or > 50 mm in women.
Clinically evident congestive heart failure: Compatible symptoms and signs, and BNP ≥ 35 pg/mL or NT-proBNP ≥ 125 pg/mL, and LV systolic dysfunction defined by LVEF < 45 %.
Coronary angiography showing stenosis ≤ 50 % in all major epicardial vessels.
Disqualifiers
Patients with coronary artery disease, hypertensive heart disease, rheumatic valvular heart disease, myocarditis, and other secondary cardiomyopathies.
poor angiographic image quality
Trial population
Patients aged ≥ 18 years with angiography-confirmed absence of coronary stenosis and a definitive diagnosis of dilated cardiomyopathy.
Trial design
Cohort
Retrospective
Treatments tested in this trial
coronary angiography
Procedure/SurgeryPatients should undergo coronary angiography to confirm the absence of significant coronary stenosis. Angio-IMR was calculated based on the angiography.
Treatment groups
Trial outcomes
Primary outcomes
Major adverse cardiac events
A composite of cardiac death, hospitalization for heart failure, heart transplantation, and device implantation
Sponsors and contacts
Click on the lead sponsor to view all of their trials.